Here's Why ResMed Inc. Stock Spiked Today
Sleep apnea specialist, ResMed, Inc. (NYSE: RMD) pleased investors with a positive fiscal first-quarter report after the bell yesterday. Another quarter of double-digit year-to-year growth on the top and bottom lines pushed the stock up as high as 11.5% this morning. The shares have since settled to a gain of 7.7% as of 3:09 p.m. EDT on Friday.
With an estimated 1 in 5 Americans suffering from breathing issues related to sleep disorders, demand for ResMed's continuous positive airway pressure (CPAP) systems was high enough to push the top line up by double digits. Fiscal first-quarter sales rose by a healthy 13%, to $523 million.
Image source: Getty Images.
Source: Fool.com
Resmed Inc. Aktie
220,80 €
-1,04 %
Mit 20 Buy-Einschätzungen und keiner einzigen Sell-Einschätzung steht die Community der Resmed Inc. Aktie positiv gegenüber.
Für Resmed Inc. ergibt sich ein Potenzial von -2.17%, obwohl das Kursziel von 216 € den aktuellen Kurs von 220.8 € unterschreitet.
